A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches

Blockade of programmed cell death protein 1 (PD-1) immune checkpoint receptor signaling is an established standard treatment for many types of cancer and indications are expanding. Successful clinical trials using monoclonal antibodies targeting PD-1 signaling have boosted preclinical research, enco...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Versteven, Maarten, Van den Bergh, Johan M.J., Broos, Katrijn, Fujiki, Fumihiro, Campillo-Davo, Diana, De Reu, Hans, Morimoto, Soyoko, Lecocq, Quentin, Keyaerts, Marleen, Berneman, Zwi, Sugiyama, Haruo, Van Tendeloo, Viggo F.I., Breckpot, Karine, Lion, Eva
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6021243/
https://ncbi.nlm.nih.gov/pubmed/29963238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25591
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados